Local Empowerment for Advocacy Development (LEAD) Grant

CSL Behring offers the Local Empowerment for Advocacy Development (LEAD) Grant program to support local patient advocacy organizations working on issues relevant to individuals who use plasma-derived or recombinant therapies. These grants are designed to empower grassroots efforts and strengthen the voice of patients in public policy decisions that affect their care and treatment options. The LEAD Grants reflect CSL Behring’s belief that patients are best equipped to advocate for themselves and that local organizations can be powerful catalysts for change. LEAD Grants provide approximately $10,000 in funding to nonprofit, 501(c)(3) patient organizations within the United States. The program is intended to support advocacy initiatives that target local or state legislative and regulatory issues. Applicants must currently be engaged in or plan to undertake advocacy work on issues affecting patients who rely on plasma-based or recombinant therapies, including individuals with bleeding disorders, immune deficiencies, Alpha 1 deficiency, Hereditary Angioedema, CIDP, or similar conditions. Funded proposals might include advocacy campaigns to advance or block state legislation, grassroots organizing for state-level lobbying efforts, or policy research and communication initiatives. Example activities include pursuing legislation to improve care standards, increasing access to therapies, or developing infrastructure to mobilize stakeholders and influence public policy. CSL Behring may also provide collaborative support to help advance grantee objectives beyond financial assistance. To apply, organizations must complete and submit the LEAD Grant application form, which includes detailed information about the advocacy issue being addressed, the expected impact, the timeline and milestones, and a proposed budget. Supporting documents are encouraged, particularly for coalitions, which must also include letters of support from partner members. All grant recipients are required to submit a six-month progress report detailing achievements and activities. Applications for the U.S. LEAD Grant are accepted annually between October 1 and October 31. Completed applications may be submitted via email or mailed directly to the CSL Behring LEAD Grant Committee in King of Prussia, Pennsylvania. Grant recipients will be announced in December each year. Questions may be directed to advocacy@cslbehring.com.

Address a clearly defined public policy issue; articulate community impact; include supporting materials to strengthen case.